关注
Stephen N. Crooke
Stephen N. Crooke
Vaccine Immunology Team Lead, Centers for Disease Control and Prevention
在 cdc.gov 的电子邮件经过验证
标题
引用次数
年份
1148. Long-term Persistence of Measles and Rubella Virus Neutralizing Antibody Levels among Adults with Three Doses of Measles-Mumps-Rubella Vaccine
O Alonge, M Marin, CJ Hickman, SB Sowers, M Chen, L Hao, J Icenogle, ...
Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 989, 2023
2023
3, 6-Bis (5’-bromo-3’-indolyl)-1, 4-dimethypiperazine-2, 5-dione
S Crooke, M Davis-McGibony, C Whitlock
Molbank 2009 (4), M627, 2009
22009
A General Synthesis of Bis-indolylpiperazine-2, 5-diones
S Crooke, C Whitlock
Molecules 17 (12), 14841-14845, 2012
92012
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial
I Adigweme, M Yisa, M Ooko, E Akpalu, A Bruce, S Donkor, LB Jarju, ...
The Lancet 403 (10439), 1879-1892, 2024
32024
A nonaggregating heptamethine cyanine for building brighter labeled biomolecules
MP Luciano, SN Crooke, S Nourian, I Dingle, RR Nani, G Kline, NL Patel, ...
ACS Chemical Biology 14 (5), 934-940, 2019
582019
Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine
SN Crooke, IG Ovsyannikova, RB Kennedy, ND Warner, GA Poland
Vaccine 38 (50), 7897-7904, 2020
32020
Breakthrough Measles among Vaccinated Adults Born during the Post-Soviet Transition Period in Mongolia
JE Hagan, SN Crooke, N Gunregjav, SB Sowers, S Mercader, ...
Vaccines 12 (6), 695, 2024
2024
Chemical and genetic modification of virus-like particles for applications in vaccine design and drug delivery
SN Crooke
Georgia Institute of Technology, 2018
2018
Corrigendum to “Seroprevalence and durability of rubella virus antibodies in a highly immunized population”.[Vaccine 37 (2019) 3876–3882]
SN Crooke, IH Haralambieva, DE Grill, IG Ovsyannikova, RB Kennedy, ...
Vaccine 38 (43), 6858, 2020
2020
Cure from the sea: Synthesis of dragmacidin derivatives
SN Crooke, CR Whitlock
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 243, 2012
2012
Cure from the Sea: Synthesis of dragmacidin derivatives for cancer treatments
SN Crooke, CM Davis-McGibony, CR Whitlock
2010
Degradable hydrogels for the delivery of immune-modulatory proteins in the wound environment
MD Johnson, J Lloyd, S Tekkam, SN Crooke, DA Witherden, WL Havran, ...
ACS applied bio materials 3 (8), 4779-4788, 2020
132020
Development of Autologous C5 Vaccine Nanoparticles to Reduce Intravascular Hemolysis in Vivo
L Zhang, W Qiu, S Crooke, Y Li, A Abid, B Xu, MG Finn, F Lin
ACS chemical biology 12 (2), 539-547, 2017
192017
Digital Commons@ Georgia Souther n
CN Written, VN Heard
2010
Disease Description
NB Masters, J Leung, J Tappe, M Marin, SN Crooke, B Bankamp, S Oliver, ...
Durability of humoral immune responses to rubella following MMR vaccination
SN Crooke, MM Riggenbach, IG Ovsyannikova, ND Warner, MH Chen, ...
Vaccine 38 (51), 8185-8193, 2020
122020
gamma delta T cells and the regulation of immune responses at epithelial surfaces
W Havran, M Johnson, A Borkowski, S Tekkam, S Crooke, MG Finn, ...
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 255-255, 2016
2016
Getting a Head Start: The Benefits of Starting Undergraduate Research as a Freshman
SN Crooke, CM Davis McGibony, CR Whitlock
The Chemical Educator 17, 211, 2012
2012
Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects
SN Crooke, IG Ovsyannikova, RB Kennedy, GA Poland
PloS one 16 (6), e0252198, 2021
102021
Identifying a level of neutralizing antibody that correlates with protection from clinical mumps disease during a 2017 mumps outbreak among military service members
SB Sowers, NS Clemmons, S Mercader, L Nielsen, H Colley, NN Jordan, ...
Open Forum Infectious Diseases, ofae329, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20